Efficacy of Pyridostigmine in Myasthenia Gravis

Key Points

• This research aims to evaluate the effectiveness of pyridostigmine in alleviating symptoms of myasthenia gravis (MG).
• Class I evidence study design
• Involves adults with acetylcholine receptor (AChR) ab-positive MG
• Comparison of pyridostigmine to placebo
• Participants are on stable standard-of-care therapy
• Pyridostigmine significantly improves MG symptoms compared to placebo
• Results provide strong support for pyridostigmine in symptom management of MG

Abstract